Left ventricular hypertrophy in pediatric patients on maintenance dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).
Cardiovascular
Children
Dialysis
Hypertension
Kidney failure
Left ventricular hypertrophy
Journal
Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
received:
29
03
2022
accepted:
18
10
2022
revised:
17
10
2022
medline:
4
5
2023
pubmed:
11
11
2022
entrez:
10
11
2022
Statut:
ppublish
Résumé
Cardiovascular disease is the leading cause of death in pediatric patients with kidney failure. Left ventricular hypertrophy (LVH) is recognized as the most common cardiovascular abnormality in these patients. There remains a paucity of longitudinal studies evaluating LVH during maintenance dialysis in children. NAPRTCS has collected echocardiographic data of pediatric maintenance dialysis patients since 2013 and is one of the largest registries to assess longitudinal changes in LVH. Patients aged 1-18 years with echocardiographic data and without underlying structural cardiovascular diseases were included. LVH was defined as left ventricular mass index (LVMI, height-indexed) > 95th percentile for age and sex. Univariate and multivariable logistic regression was performed to assess risk factors for LVH at baseline. Generalized estimating equation was used to assess risk factors of changes in LVH during maintenance dialysis. A total of 518 patients had echocardiographic data available for analysis during time on maintenance dialysis. Of 179 patients with baseline echocardiography (within 30 days of dialysis initiation), 67% had LVH. In multivariable logistic regression adjusted for age, race, and sex, uncontrolled hypertension (OR 9.4, 95% CI 2.8-31) and anemia (OR 2.3, 95% CI 1.0-5.3) were associated with LVH at baseline. Prevalence of LVH remained high at 40-50% during follow-up. Controlled and uncontrolled hypertension as well as phosphorus level were independently associated with increased likelihood of LVH during maintenance dialysis. LVH is prevalent in pediatric patients at dialysis initiation and remains prevalent during follow-up. Hypertension is the strongest risk factor for LVH in children on maintenance dialysis. A higher resolution version of the Graphical abstract is available as Supplementary information.
Sections du résumé
BACKGROUND
Cardiovascular disease is the leading cause of death in pediatric patients with kidney failure. Left ventricular hypertrophy (LVH) is recognized as the most common cardiovascular abnormality in these patients. There remains a paucity of longitudinal studies evaluating LVH during maintenance dialysis in children. NAPRTCS has collected echocardiographic data of pediatric maintenance dialysis patients since 2013 and is one of the largest registries to assess longitudinal changes in LVH.
METHODS
Patients aged 1-18 years with echocardiographic data and without underlying structural cardiovascular diseases were included. LVH was defined as left ventricular mass index (LVMI, height-indexed) > 95th percentile for age and sex. Univariate and multivariable logistic regression was performed to assess risk factors for LVH at baseline. Generalized estimating equation was used to assess risk factors of changes in LVH during maintenance dialysis.
RESULTS
A total of 518 patients had echocardiographic data available for analysis during time on maintenance dialysis. Of 179 patients with baseline echocardiography (within 30 days of dialysis initiation), 67% had LVH. In multivariable logistic regression adjusted for age, race, and sex, uncontrolled hypertension (OR 9.4, 95% CI 2.8-31) and anemia (OR 2.3, 95% CI 1.0-5.3) were associated with LVH at baseline. Prevalence of LVH remained high at 40-50% during follow-up. Controlled and uncontrolled hypertension as well as phosphorus level were independently associated with increased likelihood of LVH during maintenance dialysis.
CONCLUSIONS
LVH is prevalent in pediatric patients at dialysis initiation and remains prevalent during follow-up. Hypertension is the strongest risk factor for LVH in children on maintenance dialysis. A higher resolution version of the Graphical abstract is available as Supplementary information.
Identifiants
pubmed: 36357637
doi: 10.1007/s00467-022-05796-8
pii: 10.1007/s00467-022-05796-8
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1925-1933Informations de copyright
© 2022. The Author(s), under exclusive licence to International Pediatric Nephrology Association.
Références
Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF (2000) Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 14:898–902. https://doi.org/10.1007/s004670000303
doi: 10.1007/s004670000303
pubmed: 10975295
Bakkaloglu SA, Borzych D, Soo Ha I, Serdaroglu E, Büscher R, Salas P, Patel H, Drozdz D, Vondrak K, Watanabe A, Villagra J, Yavascan O, Valenzuela M, Gipson D, Ng KH, Warady BA, Schaefer F, International Pediatric Peritoneal Dialysis Network (2011) Cardiac geometry in children receiving chronic peritoneal dialysis: findings from the International Pediatric Peritoneal Dialysis Network (IPPN) registry. Clin J Am Soc Nephrol 6:1926–1933. https://doi.org/10.2215/CJN.05990710
doi: 10.2215/CJN.05990710
pubmed: 21737855
pmcid: 3359542
Melhem N, Savis A, Wheatley A, Copeman H, Willmott K, Reid CJD, Simpson J, Sinha MD (2019) Improved blood pressure and left ventricular remodelling in children on chronic intermittent haemodialysis: a longitudinal study. Pediatr Nephrol 34:1811–1820. https://doi.org/10.1007/s00467-019-04272-0
doi: 10.1007/s00467-019-04272-0
pubmed: 31098707
Mitsnefes MM, Barletta GM, Dresner IG, Chand DH, Geary D, Lin JJ, Patel H (2006) Severe cardiac hypertrophy and long-term dialysis: the Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol 21:1167–1170. https://doi.org/10.1007/s00467-006-0180-9
doi: 10.1007/s00467-006-0180-9
pubmed: 16807760
Mitsnefes MM, Daniels SR, Schwartz SM, Khoury P, Strife CF (2001) Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr Nephrol 16:318–323. https://doi.org/10.1007/s004670000557
doi: 10.1007/s004670000557
pubmed: 11354774
Ulinski T, Genty J, Viau C, Tillous-Borde I, Deschênes G (2006) Reduction of left ventricular hypertrophy in children undergoing hemodialysis. Pediatr Nephrol 21:1171–1178. https://doi.org/10.1007/s00467-006-0122-6
doi: 10.1007/s00467-006-0122-6
pubmed: 16850307
Yu JJ, Jun HO, Shin EJ, Baek JS, Lee JH, Kim YH, Park YS, Ko JK (2018) Factors associated with reduction of left ventricular mass in children on peritoneal dialysis. Nephrology (Carlton) 23:338–344. https://doi.org/10.1111/nep.13033
doi: 10.1111/nep.13033
pubmed: 28199756
Borzych D, Bakkaloglu SA, Zaritsky J, Suarez A, Wong W, Ranchin B, Qi C, Szabo AJ, Coccia PA, Harambat J, Mitu F, Warady BA, Schaefer F, International Pediatric Peritoneal Dialysis Network (2011) Defining left ventricular hypertrophy in children on peritoneal dialysis. Clin J Am Soc Nephrol 6:1934–1943. https://doi.org/10.2215/CJN.11411210
doi: 10.2215/CJN.11411210
pubmed: 21737857
pmcid: 3359533
Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM, Children SOSAMOHBPI (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140:e20171904. https://doi.org/10.1542/peds.2017-1904
doi: 10.1542/peds.2017-1904
pubmed: 28827377
Khoury PR, Mitsnefes M, Daniels SR, Kimball TR (2009) Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 22:709–714. https://doi.org/10.1016/j.echo.2009.03.003
doi: 10.1016/j.echo.2009.03.003
pubmed: 19423289
Ozçakar ZB, Yalçinkaya F, Tutar E, Cakar N, Uçar T, Elhan A, Acar B, Yüksel S, Uncu N, Kara N, Atalay S, Ekim M (2006) Hypertension and left ventricular hypertrophy in pediatric peritoneal dialysis patients: ambulatory blood pressure monitoring and echocardiographic evaluation. Nephron Clin Pract 104:c101-106. https://doi.org/10.1159/000093997
doi: 10.1159/000093997
pubmed: 16785736
Park SK, Jung JY, Kang JG, Hong HP, Oh CM (2020) Association of left ventricular hypertrophy with hemoglobin levels in nonanemic and anemic populations. Cardiology 145:485–491. https://doi.org/10.1159/000508034
doi: 10.1159/000508034
pubmed: 32544916
Bakkaloglu SA, Saygili A, Sever L, Noyan A, Akman S, Ekim M, Aksu N, Doganay B, Yildiz N, Duzova A, Soylu A, Alpay H, Sonmez F, Civilibal M, Erdem S, Kardelen F (2009) Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report. Nephrol Dial Transplant 24:3525–3532. https://doi.org/10.1093/ndt/gfp297
doi: 10.1093/ndt/gfp297
pubmed: 19541662
London G (2001) Pathophysiology of cardiovascular damage in the early renal population. Nephrol Dial Transplant 16(Suppl 2):3–6. https://doi.org/10.1093/ndt/16.suppl_2.3
doi: 10.1093/ndt/16.suppl_2.3
pubmed: 11369841